$PFE Pfizer and BioNTech $BNTX expect to start a Phase 2b/3 trial as soon as later this month and to manufacture up to 100M doses by end of 2020 and potentially more than 1.2B doses by end of 2021
(More at https://t.co/xWc5kQ0Sno)